Updated Information for Satellite feed: Video B-Roll Via Satellite: IMI Licenses Non-Invasive Predictive Test for Cardiovascular Disease to McNeil Consumer Healthcare (J&J) for Worldwide Markets TORONTO, June 1 /PRNewswire-FirstCall/ -- The following B-Roll is available at the listed time and coordinates: DATE OF FEED: Tuesday June 1, 2004 TIME: 10:00 - 10:15 AM ET COORDINATES: AMC 9, Transponder 4 Audio subcarrier 6.2 and 6.8 Downlink frequency 3780 horizontal STORY SUMMARY: IMI International Medical Innovations Inc. (TSX:IMI; Amex: IME), a world leader in predictive medicine, today announced an exclusive worldwide non-Canadian licensing agreement with McNeil Consumer Healthcare, a Johnson & Johnson company, for IMI's non-invasive cardiovascular risk assessment technology. McNeil and its worldwide affiliates will market and distribute IMI's predictive tests for coronary artery disease under the brand name PREVU(x) Coronary Heart Disease Predictor. PREVU(x) Coronary Heart Disease Predictor is the world's only rapid, non-invasive test for coronary artery disease. PREVU(x), which does not require fasting or the drawing of blood, tests the amount of sterol, or cholesterol, in the skin tissue. Clinical studies have shown that as cholesterol accumulates on artery walls it also accumulates in other tissues, including the skin. High levels of skin sterol are correlated with higher incidence of coronary artery disease. IMI's technology, which is being adapted into three different test formats for medical, laboratory and home use, measures the level of sterol in the skin by generating a color-change reaction to generate a quantifiable result. Stations, for FURTHER INFORMATION, please contact: Sarah Borg-Olivier, Director, Communications, T: 416-222-3449 ext. 27. FOR TECHNICAL ASSISTANCE, please contact CFA at (416) 504-5071 ext. 350. As with all CNW Broadcast feeds, this release is offered for your free and unrestricted news use. DATASOURCE: CNW Broadcast Services CONTACT: STATIONS: Sarah Borg-Olivier, Director, Communications, T: (416) 222-3449 ext. 27; FOR TECHNICAL ASSISTANCE, please contact CFA at (416) 504-5071 ext. 350.

Copyright